Petrelintide not checked

Zealand Pharma · ZP8396

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
7 in total · 4 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Impaired Hepatic Function
Main trialPhase 1
“This clinical research trial is testing the investigational medicinal product (IMP) petrelintide that is being developed for body weight reduction in people living with obesity or overweight who have comorbidities. The aim of this clinical research trial is to investigate whether the pharmacokinetics (PK) of petrelintide will be different in people with hepatic impairment (HI) compared to people with normal hepatic function.”In the company’s words, NCT07682818 on ClinicalTrials.gov
Other names
ZP8396

Other drugs for Impaired Hepatic Function

All 19 drugs for Impaired Hepatic Function

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 1Recruiting 12 Apr 2027 Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function
Phase 2Completed 30 Sep 2025 Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Phase 2Completed 13 Aug 2026 Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
Phase 1Completed 12 Jan 2023 A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
Phase 1Completed 13 Jun 2024 A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
Phase 1Completed 25 Nov 2025 Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Phase 1Completed 31 Mar 2026 Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Petrelintide

Following is part of Solo: you see every change to Petrelintide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in